Dactylitis: Pathogenesis and clinical considerations

Current Rheumatology Reports

Volumn 8, Issue 5, 2006, Pages 338-341

  Healy, Paul J ^b   Helliwell, Philip S ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; INFLIXIMAB; LEFLUNOMIDE; PLACEBO; SALAZOSULFAPYRIDINE;

CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; DACTYLITIS; ENTHESITIS; HUMAN; JOINT SWELLING; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATHOGENESIS; PATHOPHYSIOLOGY; PSORIATIC ARTHRITIS; REVIEW; SOFT TISSUE; SYNOVITIS; TENOSYNOVITIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, PSORIATIC; BIOLOGICAL FACTORS; FINGER JOINT; GLUCOCORTICOIDS; HUMANS; PROGNOSIS;

EID: 33750422181     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-006-0062-y     Document Type: Review

References (41)

1. Rothschild BM, Pingitore C, Eaton M: Dactylitis: implications for clinical practice. Semin Arthritis Rheum 1998, 28:41-47.
2. Brockbank JE, Stein M, Schentag CT, Gladman DD: Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 2005, 64:188-190.
3. Petty RE, Southwood TR, Manners P, et al.: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004, 31:390-392.
4. Padula A, Scarano E, Giasi V, Olivieri I: Juvenile onset isolated HLA-B27-associated dactylitis. Semin Arthritis Rheum, 2003, 32:341-342.
5. Abril A, Cohen MD: Rheumatologic manifestations of sarcoidosis. Curr Opin Rheumatol 2004, 16:51-55.
6. Stevens MC, Padwick M, Serjeant GR: Observations on the natural history of dactylitis in homozygous sickle cell disease. Clin Pediatr (Phila) 1981, 20:311-317.
7. Miller ST, Sleeper LA, Pegelow CH, et al.: Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 2000, 342:83-89.
8. Gill FM, Sleeper LA, Weiner SJ, et al.: Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. Blood 1995, 86:776-783.
9. Martini M, Adjrad A, Boudjemaa A: Tuberculous osteomyelitis. A review of 125 cases. Int Orthop 1986, 10:201-207.
10. Halsey JP, Reeback JS, Barnes CG: A decade of skeletal tuberculosis. Ann Rheum Dis 1982, 41:7-10.
11. Andronikou S, Smith B: "Spina ventosa"-tuberculous dactylitis. Arch Dis Child 2002, 86:206.
12. Schwartzenberg JM, Smith DD, Lindsley HB: Bacillus Calmette-Guerin associated arthropathy mimicking undifferentiated spondyloarthropathy. J Rheumatol 1999, 26:933-935.
13. Bhatty MA, Turner DP, Chamberlain ST: Mycobacterium marinum hand infection: case reports and review of literature. Br J Plast Surg 2000, 53:161-165.
14. Parras F, Ezpeleta C, Romero J, et al.: Blistering distal dactylitis in an adult. Cutis 1988, 41:127-128.
15. Benson PM, Solivan G: Group B streptococcal blistering distal dactylitis in an adult diabetic. J Am Acad Dermatol 1987, 17:310-311.
16. Ozgocmen S, Ardicoglu O, Ozcakar L: Dactylitis in a patient with brucellosis. J Hand Surg [Br] 2001, 26:171-172.
17. Dubost JJ, Constantin A, Soubrier M, et al.: Does reactive arthritis caused by Brucella exist? Apropos of 4 cases [in French]. Presse Med 1997, 26:207-210.
18. Olivieri I, Barozzi L, Favaro L, et al.: Dactylitis in patients with seronegative spondylarthropathy. Assessment by ultrasonography and magnetic resonance imaging. Arthritis Rheum 1996, 39:1524-1528.
19. Olivieri I, Barozzi L, Pierro A, et al.: Toe dactylitis in patients with spondyloarthropathy: assessment by magnetic resonance imaging. J Rheumatol 1997, 24:926-930.
20. Padula A, Salvarani C, Barozzi L, et al.: Dactylitis also involving the synovial sheaths in the palm of the hand: two more cases studied by magnetic resonance imaging. Ann Rheum Dis 1998, 57:61-62.
21. Olivieri I, Scarano E, Padula A, Giasi V: Dactylitis involving most of the fingers. Clin Exp Rheumatol 2003, 21:406.
22. Olivieri I, Scarano E, Padula A, Giasi V: Dactylitis of the thumb extending to the radial bursa. J Rheumatol 2003, 30:1626-1627.
23. Olivieri I, Salvarani C, Cantini F, et al.: Fast spin echo-T2-weighted sequences with fat saturation in dactylitis of spondylarthritis. No evidence of entheseal involvement of the flexor digitorum tendons. Arthritis Rheum 2002, 46:2964-2967.
24. Kane D, Greaney T, Bresnihan B, et al.: Ultrasonography in the diagnosis and management of psoriatic dactylitis. J Rheumatol 1999, 26:1746-1751.
25. McGonagle D, Gibbon W, and Emery P: Classification of inflammatory arthritis by enthesitis. Lancet 1998, 352:1137-1140.
26. Benjamin M, Moriggl B, Brenner E, et al.: The "enthesis organ" concept: why enthesopathies may not present as focal insertional disorders. Arthritis Rheum 2004, 50:3306-3313.
27. McGonagle D, Conaghan PG, Emery P: Psoriatic arthritis: a unified concept twenty years on. Arthritis Rheum 1999, 42:1080-1086.
28. Lories RJ, Matthys P, de Vlam K, et al.: Ankylosing enthesitis, dactylitis, and onychoperiostitis in male DBA/1 mice: a model of psoriatic arthritis. Ann Rheum Dis 2004, 63:595-598.
29. Bennett OM: Salmonella osteomyelitis and the hand-foot syndrome in sickle cell disease. J Pediatr Orthop 1992, 12:534-538.
30. Vanmarsenille JM, de Berg B, Houssiau FA, de Selys J: Unusually prolonged course of tuberculous dactylitis with osteitis. Joint Bone Spine 2003, 70:535-537.
31. Sunderamoorthy D, Gupta V, Bleetman A: TB or not TB: an unusual sore finger. Emerg Med J 2001, 18:490-491.
32. Rodriguez-Gomez M, Fernandez-Sueiro JL, Willisch A, et al.: Multifocal dactylitis as the sole clinical expression of sarcoidosis. J Rheumatol 2000, 27:245-247.
33. Clegg DO, Reda DJ, Mejias E, et al.: Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study. Arthritis Rheum 1996, 39:2013-2020.
34. Salvarani C, Cantini F, Olivieri I, et al.: Efficacy of infliximab in resistant psoriatic arthritis. Arthritis Rheum 2003, 49:541-545.
35. Kaltwasser JP, Nash P, Gladman D, et al.: Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 2004, 50:1939-1950.
36. Antoni CE, Kavanaugh A, Kirkham B, et al.: Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT). Arthritis Rheum 2005, 52:1227-1236.
37. [Published erratum appears in Arthritis Rheum 2005, 52:2951.]
38. Antoni C, Krueger GG, de Vlam K, et al.: Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005, 64:1150-1157.
39. Helliwell PS, Firth J, Ibrahim GH, et al.: Development of an assessment tool for dactylitis in patients with psoriatic arthritis. J Rheumatol 2005, 32:1745-1750. Charts the development and testing of a new objective dactylitis tool.
40. Helliwell PS: Therapies for dactylitis in psoriatic arthritis. A systematic review. J Rheumatol 2006, In press. A comprehensive review of therapy for dactylitis.
41. Salvarani C, Macchioni P, Olivieri I, et al.: A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol 2001, 28:2274-2282.